Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23628459)

1.

Glucosylceramide modulates endolysosomal pH in Gaucher disease.

Sillence DJ.

Mol Genet Metab. 2013 Jun;109(2):194-200. doi: 10.1016/j.ymgme.2013.03.015. Epub 2013 Apr 3.

PMID:
23628459
2.

Glucosylceramide modulates membrane traffic along the endocytic pathway.

Sillence DJ, Puri V, Marks DL, Butters TD, Dwek RA, Pagano RE, Platt FM.

J Lipid Res. 2002 Nov;43(11):1837-45.

3.
4.

In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.

Prence EM, Chaturvedi P, Newburg DS.

J Neurosci Res. 1996 Feb 1;43(3):365-71.

PMID:
8714525
5.

Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.

Campeau PM, Rafei M, Boivin MN, Sun Y, Grabowski GA, Galipeau J.

Blood. 2009 Oct 8;114(15):3181-90. doi: 10.1182/blood-2009-02-205708. Epub 2009 Jul 8.

6.

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.

Aflaki E, Stubblefield BK, Maniwang E, Lopez G, Moaven N, Goldin E, Marugan J, Patnaik S, Dutra A, Southall N, Zheng W, Tayebi N, Sidransky E.

Sci Transl Med. 2014 Jun 11;6(240):240ra73. doi: 10.1126/scitranslmed.3008659.

7.

Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.

Akiyama H, Kobayashi S, Hirabayashi Y, Murakami-Murofushi K.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):838-43. doi: 10.1016/j.bbrc.2013.10.145. Epub 2013 Nov 6.

8.

Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.

Trajkovic-Bodennec S, Bodennec J, Futerman AH.

Blood Cells Mol Dis. 2004 Jul-Aug;33(1):77-82.

PMID:
15223015
10.

Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.

Newburg DS, Shea TB, Yatziv S, Raghavan SS, McCluer RH.

Exp Mol Pathol. 1988 Jun;48(3):317-23.

PMID:
3371456
11.

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D.

Cell. 2011 Jul 8;146(1):37-52. doi: 10.1016/j.cell.2011.06.001. Epub 2011 Jun 23.

13.

Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.

Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH.

J Biol Chem. 1999 Jul 30;274(31):21673-8.

14.

Gaucher disease: pathological mechanisms and modern management.

Jmoudiak M, Futerman AH.

Br J Haematol. 2005 Apr;129(2):178-88. Review.

PMID:
15813845
15.

Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.

Sasagasako N, Kobayashi T, Yamaguchi Y, Shinnoh N, Goto I.

J Biochem. 1994 Jan;115(1):113-9.

16.

Enhanced calcium release in the acute neuronopathic form of Gaucher disease.

Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, Sidransky E, Schiffmann R, Futerman AH.

Neurobiol Dis. 2005 Feb;18(1):83-8.

PMID:
15649698
17.

Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention.

Groener JE, Poorthuis BJ, Kuiper S, Hollak CE, Aerts JM.

Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):72-8. Epub 2007 Dec 5.

PMID:
18155675
18.

Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.

Schueler UH, Kolter T, Kaneski CR, Zirzow GC, Sandhoff K, Brady RO.

J Inherit Metab Dis. 2004;27(5):649-58.

PMID:
15669681
19.

Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms.

Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, de-Morgan A, Waller H, Schiffmann R, Futerman AH.

J Biol Chem. 2003 Jun 27;278(26):23594-9. Epub 2003 Apr 22.

20.

Neuronal forms of Gaucher disease.

Vitner EB, Futerman AH.

Handb Exp Pharmacol. 2013;(216):405-19. doi: 10.1007/978-3-7091-1511-4_20. Review.

PMID:
23563668
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk